April 2021

Do no harm: An interview with David Newns

The son of a biscuit factory worker, growing up in a poor part of Blackpool, from an early age Newns had a goal to be financially independent. Now 36, Newns has founded and helmed two companies in the e-cigarette sector which sold for a combined £150m to FTSE 100 companies. He was one of the youngest-ever FTSE 100 executives in the UK, and, with his business partner he has registered more than 800 patents in the harm reduction and tech sectors – they are the 11th most prolific intellectual property filers in the UK. He is now spearheading a venture in wearable AI sports tech, as well as investing and advising promising tech start-ups from all over the world, while he splits his time between homes in Verbier, Ibiza and Cheshire. 

Do no harm: An interview with David Newns Read More »

How curing cataracts offers a 1,500% socio-economic return

According to the World Health Organisation, 95 million people worldwide are affected by blindness or severe visual impairment due to cataracts.  Cataracts are disproportionately prevalent in low-and-middle-income countries, where they account for 50% of blindness, compared to just 5% of blindness within developed countries.

How curing cataracts offers a 1,500% socio-economic return Read More »

AI-Powered Ubiquitous Investing

Have you noticed that your bank statements are now a succession of Netflix, Uber, Spotify, Deliveroo, Apple, and Amazon payments? All of them offer us all types of services at our fingertips. No more wasting time sourcing or waiting to access the best way to get an amazing selection of food, music, films, transport, or products. Everything is now just one click away, curated for us and AI-matched to our deepest desires in exchange for money. Click and pay and almost anything can become yours to enjoy!

AI-Powered Ubiquitous Investing Read More »

AI on the edge

Artificial intelligence (AI) has already been attracting the attention of deep tech investors for some years. The reasons why are clear. In its ‘Sizing The Prize’ analysis of artificial intelligence (AI), PwC forecast that AI will contribute $15.7 trillion to the global economy by 2030, with the ‘AI boost’ available to most national economies being approximately 26%. But what investors often overlook is that AI is not singular. Many individual components must work together to create AI.

AI on the edge Read More »

London investor Tej Kohli on chasing the ‘second wave’ of CRISPR-Cas9

“The only thing worse than losing money on an investment is having to watch the value of something that you didn’t back grow beyond all expectations” says London-based technologist and investor Tej Kohli. Kohli is talking into a laptop with the team of experts that he has assembled to spearhead a new initiative for his Kohli Ventures investment vehicle. Staring back at Kohli are the faces of a crack team of PhD and MBA holders from the worlds of biotechnology and genetic engineering.

London investor Tej Kohli on chasing the ‘second wave’ of CRISPR-Cas9 Read More »

The Accelerating Competition in the Bionic Hand Industry

Roll forward six years and at BionicsForEveryone.com we now list 14 bionic hands from 13 companies on our website, with another 5 devices likely to be added before the end of 2021. The lowest-priced hand on that list is currently $8,000. There are three more that sell for less than $18,000, and that includes a forearm socket and also prosthetist fees.

The Accelerating Competition in the Bionic Hand Industry Read More »